Omnix Medical Launches New Horizon Europe PEPTAMR Infectious Disease Consortium
— EUR ~8M grant supports the late-stage clinical development of Omnix’s antimicrobial OMN6 — Leading European partners join forces to advance OMN6 for the treatment of life-threatening hospital-acquired infections JERUSALEM, Israel, July 13, 2026 — Omnix Medical, a biopharmaceutical company developing next-generation anti-infectives for the treatment of life-threatening infections, today announced the launch of […]